phrykt

Medtronic plc (MDT): who owns it and who trades it

As of Nov 16, 2026, MDT insiders reported 18 open-market sales worth $14.7M and no purchases in the last 12 months, with 41% of the sale value made under pre-set 10b5-1 plans. The largest seller was Harry Skip Kiil (Vice president), with $5.6M. 9 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Medtronic

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MDT

2,121 funds and institutions reported MDT shares worth $87.7B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 8.9%.

Funds and institutions (13F) 86%Everyone else 14%

10 largest owners, by share of the company

BlackRock, Inc.8.9%
Vanguard Capital Management LLC6.5%
State Street Corp5.0%
Vanguard Portfolio Management LLC2.7%
Geode Capital Management, LLC2.4%
JPMorgan Chase & Co2.2%
First Eagle Investment Management, LLC2.2%
Bank of America Corp1.7%
Massachusetts Financial Services Co1.6%
Morgan Stanley1.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.114.02M8.91%$8.9B+1%
Vanguard Capital Management LLC83.82M6.55%$6.6B+1%
State Street Corp63.40M4.95%$5B+3%
Vanguard Portfolio Management LLC34.06M2.66%$2.7B+2%
Geode Capital Management, LLC30.19M2.36%$2.4B+5%
JPMorgan Chase & Co27.78M2.17%$2.2B–
First Eagle Investment Management, LLC27.57M2.15%$2.2B+174%
Bank of America Corp21.32M1.67%$1.7B-18%
Massachusetts Financial Services Co19.87M1.55%$2.6B-7%
Morgan Stanley19.44M1.52%$1.5B-6%
Deutsche Bank Ag\18.45M1.44%$1.4B-3%
Invesco Ltd.17.89M1.40%$1.4B+7%
Franklin Resources Inc17.55M1.37%$1.4B+24%
Norges Bank16.55M1.29%$1.3B–
Royal Bank of Canada16.03M1.25%$1.3B+13%
Bank of New York Mellon Corp14.69M1.15%$1.1B-5%
Capital Research Global Investors13.26M1.04%$1B-68%
Arrowstreet Capital, Limited Partnership12.89M1.01%$1B+177%
Northern Trust Corp11.63M0.91%$910M-3%
Ameriprise Financial Inc11.57M0.90%$905M-3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MDT insiders reported $0 of open-market purchases and $14.7M of sales. 41% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$14.7M
18 trades, 5 people
Sales under a 10b5-1 plan
41%
Share of sale value
Latest trade
Oct 15, 2026
Filed Oct 16, 2026

Purchases and sales by month

$5.8M$5.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 15, 2026Michael MarinaroVice presidentSale plan10,420$96.00$1MForm 4
Oct 15, 2026Geoffrey MarthaCEOSale plan50,000$95.00$4.8MForm 4
Sep 16, 2026Harry Skip KiilVice presidentSale1,483$93.65$139KForm 4
Jul 8, 2026Matthew R. WalterVice presidentSale plan3,102$83.15$258KForm 4
Jun 8, 2026Harry Skip KiilVice presidentSale228$80.45$18.3KForm 4
Jun 8, 2026Harry Skip KiilVice presidentSale3,961$80.44$319KForm 4
Feb 19, 2026Harry Skip KiilVice presidentSale30,568$97.66$3MForm 4
Feb 19, 2026Harry Skip KiilVice presidentSale19,255$97.77$1.9MForm 4
Feb 19, 2026Harry Skip KiilVice presidentSale385$97.82$37.7KForm 4
Feb 19, 2026Harry Skip KiilVice presidentSale1,648$97.86$161KForm 4
Feb 19, 2026Harry Skip KiilVice presidentSale668$97.83$65.4KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale500$102.08$51KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale325$102.06$33.2KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale227$102.05$23.2KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale825$102.04$84.2KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale1,995$102.03$204KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale1,942$101.99$198KForm 4
Nov 19, 2025Gregory L SmithVice presidentSale24,186$101.93$2.5MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Harry Skip KiilEVP & President Cardiovascular–$5.6MSep 16, 2026
Geoffrey MarthaChairman and CEO, Director–$4.8MOct 15, 2026
Gregory L SmithEVP Global Ops & Supply Chain–$3.1MNov 19, 2025
Michael MarinaroEVP, Pres MedSurg and Americas–$1MOct 15, 2026
Matthew R. WalterSVP, Chief HR Officer–$258KJul 8, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MDT short interest

Low short interest. 1.8% of MDT shares are sold short: about 1 share in 56. Over the last 12 reports the number of shares short went up 57%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 22.95M MDT shares were sold short, 1.8% of the shares outstanding, down 83.5% from the report before. At the average daily volume of 12.37M shares, buying them all back would take about 1.9 trading days (days to cover).

Shares short, % of all shares

1.79%May 15Oct 3012.4%

Days to cover

1.9May 15Oct 303.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202622.95M1.79%-83%12.37M1.9
Oct 15, 2026139.00M10.87%+248%47.50M2.9
Sep 30, 202639.97M3.13%+132%14.67M2.7
Sep 15, 202617.23M1.35%+42%8.73M2.0
Aug 31, 202612.13M0.95%-15%7.26M1.7
Aug 14, 202614.35M1.12%-21%6.38M2.2
Jul 31, 202618.12M1.42%-5%7.64M2.4
Jul 15, 202619.03M1.49%-0%7.78M2.5
Jun 30, 202619.09M1.49%+4%11.02M1.7
Jun 15, 202618.43M1.44%+10%12.16M1.5
May 29, 202616.76M1.31%+14%11.26M1.5
May 15, 202614.65M1.14%+0%9.88M1.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded MDT

Since Nov 17, 2024, 10 members of Congress reported 5 purchases and 13 sales of MDT. The latest was a sale by Kevin Hern on Aug 24, 2026, reported Sep 1, 2026.

Purchases 5Sales 13

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 24, 2026Kevin Hern (R-OK)Sale$15K–$50KJointSep 1, 2026Report
Jul 30, 2026Richard McCormick (GA)Sale$1K–$15KSelfAug 14, 2026Report
May 15, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJun 8, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Mar 20, 2026Kevin Hern (R-OK)Sale$15K–$50KJointApr 3, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Nov 5, 2025Richard McCormick (GA)Purchase$1K–$15KSelfDec 9, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMay 31, 2025Report
May 8, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
May 7, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointAug 5, 2026Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfApr 28, 2025Report
Mar 24, 2025George Whitesides (D-CA)Sale$50K–$100KSelfApr 23, 2025Report
Mar 20, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfApr 16, 2025Report
Mar 4, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report
Jan 6, 2025Emily Randall (D-WA)Sale$1K–$15KSpouseFeb 11, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Medtronic company events

Medtronic filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 19, 2026.

  1. Oct 19, 2026LeadershipThe Board of Directors of Medtronic plc approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026. Filing
  2. Sep 17, 2026AnnouncementMedtronic plc, a public limited company organized under the laws of Ireland, commenced an offer to exchange up to 225,361,295 newly issued shares of common stock, par value $0.01 per share, of MiniMed Group, Inc., a Delaware corporation, for outstanding ordinary shares of Medtronic, par value… Filing
  3. Sep 1, 2026ResultsReleased financial results. Filing
  4. Jun 3, 2026ResultsReleased financial results. Filing
  5. May 18, 2026LeadershipMedtronic plc announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President… Filing
  6. Apr 27, 2026AnnouncementShared information with investors. Filing
  7. Mar 24, 2026AnnouncementShared information with investors. Filing
  8. Feb 17, 2026ResultsReleased financial results. Filing
  9. Nov 18, 2025ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Medtronic makes money

Cardiovascular brought in 38% of Medtronic's revenue ($14B of $36.4B) in fiscal 2025. Neuroscience Group was next, at 28%.

By business segment, fiscal 2025

Cardiovascular$14B · 38%
Neuroscience Group$10.3B · 28%
Medical Surgical$8.8B · 24%
Diabetes and other$3.2B · 9%
Other$135M · 0%

From Medtronic's annual report (10-K) for the year ended Apr 24, 2026, filed Jun 18, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Medtronic financials

Famous investors that hold MDT

9 of the 50 well-known investors we track reported holding MDT in their latest 13F filing. The largest position is Israel Englander's, worth $671M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20267.77M$671M0.5%+746%
Ken Griffin · Citadel AdvisorsQ3 20263.77M$326M0.2%-30%
Richard Pzena · Pzena Investment ManagementQ3 20263.08M$266M0.8%-2%
Steve Cohen · Point72 Asset ManagementQ3 20262.73M$236M0.4%New
Jim Simons · Renaissance TechnologiesQ3 2026887,841$76.6M0.1%-72%
Ray Dalio · Bridgewater AssociatesQ3 2026488,043$42.1M0.2%+1%
Jeremy Grantham · GMOQ3 2026162,454$14M0.0%+128%
Ken Fisher · Fisher Asset ManagementQ3 2026113,168$9.8M0.0%-3%
Lee Ainslie · Maverick CapitalQ3 202613,323$1.1M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MDT in the last 120 days.

FiledHolderFormStake
Nov 10, 2026STATE STREET CORPORATION13G5.2%
Nov 10, 2026STATE STREET CORPORATION13G5.2%

Questions about Medtronic plc (MDT) stock

Who owns the most MDT stock?

The largest reported owner of Medtronic plc (MDT) is BlackRock, Inc., with 8.9% of the company. In total, 2,121 funds and institutions reported holding MDT at the end of Q2 2026, together about 86% of the shares. See the largest owners.

Are MDT insiders buying or selling?

In the last 12 months, MDT insiders reported no open-market purchases and 18 sales worth $14.7M. The latest trade was on Oct 15, 2026. See every trade.

What is the short interest in MDT?

As of Oct 30, 2026, 22.95M MDT shares were sold short, 1.8% of the shares outstanding, down 83.5% from the report before. At the average daily volume of 12.37M shares, buying them all back would take about 1.9 trading days (days to cover). See the history.

Have members of Congress traded MDT?

Yes. 10 members of Congress reported 5 purchases and 13 sales of MDT since Nov 17, 2024. The latest was reported on Sep 1, 2026. See the trades.

How does Medtronic make money?

Cardiovascular brought in 38% of Medtronic's revenue ($14B of $36.4B) in fiscal 2025. Neuroscience Group was next, at 28%. See the full split.

Which famous investors hold MDT?

9 of the 50 well-known investors we track reported MDT in their latest 13F filing, including Israel Englander, Ken Griffin, Richard Pzena. The largest position is worth $671M. See all holders.

Executive pay

Medtronic's chief executive was paid a total of $22.9M for the year ended Apr 24, 2026, up 8% from $21.2M the year before. In the last 12 months, Medtronic's executives and directors bought no stock on the open market and sold $14.7M.

Chief executive, total pay$22.9MYear ended Apr 24, 2026. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$22.5MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$7.3MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.